AU
Ankita Upadhyay
About Ankita Upadhyay
Data last updated:
Ankita Upadhyay is a Director at Nammada Healthcare Private Limited (since 2023) and Director at Nammada Life Sciences Private Limited (since 2026). The largest current company by reported revenue is Nammada Healthcare Private Limited at ₹55 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nammada Healthcare Private Limited U46497MP2023PTC069186 | Director | 30 Dec 2023 | 2023 | ₹55 Lakh (FY 2025) | Active |
| Nammada Life Sciences Private Limited U46497MP2026PTC086524 | Director | 25 Aug 2026 | 2026 | Active |
Board colleagues of Ankita Upadhyay
| Name | DIN | Company | Designation |
|---|---|---|---|
| Padma Vasudev Kataria | 10448399 | Nammada Healthcare Private Limited | Director |
| Anil Kumar Sen | 07744949 | Nammada Life Sciences Private Limited | Non- Individual Subscriber |
| Dharmesh Kataria | 11765562 | Nammada Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankita Upadhyay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankita Upadhyay
Ankita Upadhyay currently holds 2 directorships: Nammada Healthcare Private Limited (Director, since 30 Dec 2023, revenue ₹55 Lakh (FY 2025)); Nammada Life Sciences Private Limited (Director, since 25 Aug 2026).
Ankita Upadhyay was first appointed on 30 Dec 2023 as Director at Nammada Healthcare Private Limited. The most recent appointment on record is 25 Aug 2026 at Nammada Life Sciences Private Limited.
The current boards of Ankita Upadhyay's companies include Padma Vasudev Kataria (Nammada Healthcare Private Limited), Anil Kumar Sen (Nammada Life Sciences Private Limited), Dharmesh Kataria (Nammada Life Sciences Private Limited).